Dr. Talal Hilal, MD

Dr. Hilal practices at Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona.

Dr. Hilal's NPI, 1669813978, was assigned on July 15, 2013. Dr. Hilal graduated from Royal College of Surgeons in Ireland - Medical University of Bahrain in 2012. Dr. Hilal holds Arizona license 51698.

Dr. Hilal's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale, at 13400 East Shea Boulevard, Scottsdale, AZ 85259. The practice phone is (480) 342-4201.

Dr. Hilal's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona. Dr. Hilal is also affiliated with Mayo Clinic Hospital - Phoenix. The medical group on file is Mayo Clinic Arizona. Dmand AI also links Dr. Hilal to 1 more medical group, named with a free account. Dr. Hilal's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hilal practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Hilal's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Hilal is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Hilal's licenses on file in 4 states: Arizona, Mississippi, Oregon and Kentucky.

Dmand AI lists anemia, breast cancer, chronic anemia, chronic leukemia, immune deficiency disease, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Hilal treats.

CMS data shows 18,785 Medicare services from Dr. Hilal across 35 procedure codes in 2024, for 509 Medicare patients. Medicare paid $512,360 for them.

CMS counts 509 Medicare patients who saw Dr. Hilal in 2024. The largest group is 65 to 74, with 260 patients. 71% of them have high cholesterol, and 68% have high blood pressure. 3% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hilal's median patient age at 70, with 46% women.

In 2024, Dr. Hilal wrote 504 Medicare Part D claims for 83 patients. 60% of them were for generic drugs. CMS names the drug for 335 of them, across 14 drugs with 11 or more claims each, at $1,244,760 in total drug cost. In 2023, CMS named 209 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Hilal for performance year 2024, reported as part of a group. Dr. Hilal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hilal as offering telehealth.

Dmand AI links 63 papers to Dr. Hilal, published from 2014 to 2025. 2018 was the busiest year, with 7. The most frequent topics are Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols and Hematopoietic Stem Cell Transplantation. Dr. Hilal has published most often in JAMA Oncol. Dr. Hilal's most frequent co-authors are Jose Francisco Leis, MD, Nandita Khera, MD and Allison C. Rosenthal, DO.

CMS Open Payments shows 57 general payments to Dr. Hilal from 29 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 73% of the total. BeOne Medicines USA, Inc. paid the most, $2,445.

Dr. Hilal graduated from Royal College of Surgeons in Ireland - Medical University of Bahrain in 2012. Dr. Hilal is a member of ASCO and ASH.

Dr. Hilal is in network with 5 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.